Abstract
In this study was carried on a systematic review of the data was carried out in the topic of monoclonal antibodies in the last 40 years. All the data collected and summarized revealed that this new class of medicine may bring great advance in the field of radiopharmacy, oncology and imaging.
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Neoplasm / therapeutic use*
-
Antibody-Dependent Cell Cytotoxicity / drug effects
-
Antineoplastic Agents / immunology
-
Antineoplastic Agents / therapeutic use*
-
Complement Activation / drug effects
-
Humans
-
Neoplasms / radiotherapy*
-
Radiation Oncology / trends
-
Radioimmunotherapy / methods*
-
Radiopharmaceuticals / pharmacokinetics
-
Radiopharmaceuticals / urine*
-
Signal Transduction / drug effects
Substances
-
Antibodies, Monoclonal
-
Antibodies, Neoplasm
-
Antineoplastic Agents
-
Radiopharmaceuticals